Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses?

Nature Clinical Practice Nephrology volume 1, pages 12–13 (2005)Cite this article

boxed-textGrzeszczak W et al. (2005) The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin β in peritoneal dialysis patients with chronic renal anaemia. Nephrol Dial Transplant 20: 936–944

Once-weekly subcutaneous administration of epoetin beta is convenient and effective during the maintenance phase of treatment in stable peritoneal dialysis patients with renal anemia

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Locatelli F et al. (2002) Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study. Am J Kidney Dis 40: 119–125

    Article  CAS  Google Scholar 

  2. Weiss LG et al. (2000) The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrol Dial Transplant 15: 2014–2019

    Article  CAS  Google Scholar 

  3. Beshara S et al. (2004) Varying intervals of subcutaneous epoetin alfa in hemodialysis patients. J Nephrol 17: 525–530

    CAS  PubMed  Google Scholar 

  4. Locatelli F et al. (2004) Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19 (Suppl 2): ii1–ii47

    PubMed  Google Scholar 

  5. Tolman C et al. (2005) Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical study. J Am Soc Nephrol 16: 1463–1470

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Senior Physician in the Department of Renal Medicine at Karolinska University Hospital Huddinge, Stockholm, Sweden

    Peter Bárány

Authors
  1. Peter Bárány
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Bárány.

Ethics declarations

Competing interests

Peter Bárány has participated in working groups for the European Best Practice Guidelines and national guidelines for the management of anemia in patients with chronic renal failure. He has received honoraria and reimbursement for lectures, participation in symposia, workshops and educational activities from Roche, Janssen-Cilag and Amgen, and been involved in clinical trials sponsored by these companies. He has also received honoraria for membership of scientific advisory boards for Amgen and Vifor, and has written expert reports for Baxter and Nebo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bárány, P. Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses?. Nat Rev Nephrol 1, 12–13 (2005). https://doi.org/10.1038/ncpneph0022

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0022

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing